A novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia

被引:0
作者
Lee, Da Hee [1 ]
Lee, Hye Jin [1 ]
Yang, Gabsik [1 ]
Kim, Dae Yong [1 ]
Kim, Jong Uk [1 ]
Yook, Tae Han [1 ]
Lee, Jun Ho [1 ,2 ]
Kim, Hong Jun [1 ]
机构
[1] Woosuk Univ, Coll Korean Med, Jeonju Si 54986, South Korea
[2] Da Capo Co Ltd, Jeonju Si, South Korea
基金
新加坡国家研究基金会;
关键词
aging; clinical trials; muscle atrophy; natural products; sarcopenia; SKELETAL-MUSCLE REGENERATION; FOXO TRANSCRIPTION FACTORS; UBIQUITIN LIGASES; CONJUGATION SYSTEMS; PROTEIN-DEGRADATION; INSULIN SENSITIVITY; GENE-EXPRESSION; DOWN-REGULATION; SATELLITE CELL; ATROPHY;
D O I
10.1002/ptr.8301
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sarcopenia is a condition marked by a significant reduction in muscle mass and strength, primarily due to the aging process, which critically impacts muscle protein dynamics, metabolic functions, and overall physical functionality. This condition leads to increased body fat and reduced daily activity, contributing to severe health issues and a lower quality of life among the elderly. Recognized in the ICD-10-CM only in 2016, sarcopenia lacks definitive treatment options despite its growing prevalence and substantial social and economic implications. Given the aging global population, addressing sarcopenia has become increasingly relevant and necessary. The primary causes include aging, cachexia, diabetes, and nutritional deficiencies, leading to imbalances in protein synthesis and degradation, mitochondrial dysfunction, and hormonal changes. Exercise remains the most effective intervention, but it is often impractical for individuals with limited mobility, and pharmacological options such as anabolic steroids and myostatin inhibitors are not FDA-approved and are still under investigation. This review is crucial as it examines the potential of natural products as a novel treatment strategy for sarcopenia, targeting multiple mechanisms involved in its pathogenesis. By exploring natural products' multi-targeted effects, this study aims to provide innovative and practical solutions for sarcopenia management. Therefore, this review indicates significant improvements in muscle mass and function with the use of specific natural compounds, suggesting promising alternatives for those unable to engage in regular physical activity. Schematic overview of the possible therapeutic mechanisms involved in sarcopenia with various natural products. The global rise in aging populations has led to an increased prevalence of sarcopenia, which is becoming a new social issue. Currently, there is no FDA-approved treatment for sarcopenia; however, ongoing studies are identifying diverse factors and mechanisms involved in the condition to establish a definitive treatment protocol. Various natural products developed thus far exhibit significant potential in developing treatments by targeting these identified factors and mechanisms.image
引用
收藏
页码:5033 / 5051
页数:19
相关论文
共 50 条
  • [21] Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration
    Mitra, Sarmistha
    Dash, Raju
    Munni, Yeasmin Akter
    Selsi, Nusrat Jahan
    Akter, Nasrin
    Uddin, Md Nazim
    Mazumder, Kishor
    Moon, Il Soo
    METABOLITES, 2022, 12 (11)
  • [22] Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer
    Bian, Yan
    Wei, Juntong
    Zhao, Changsheng
    Li, Guorong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [23] Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
    Xu, Xuxu
    Han, Chaowei
    Wang, Pengcheng
    Zhou, Feimeng
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [24] Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction
    Huang, Jiewu
    Liang, Ye
    Zhou, Lili
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Targeting Natural Products for the Treatment of COVID-19-An Updated Review
    Pamuru, Ramachandra R.
    Ponneri, Naveen
    Damu, Amooru G.
    Vadde, Ramakrishna
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (41) : 5278 - 5285
  • [26] Natural products targeting ER stress pathway for the treatment of cardiovascular diseases
    Choy, Ker Woon
    Murugan, Dharmani
    Mustafa, Mohd Rais
    PHARMACOLOGICAL RESEARCH, 2018, 132 : 119 - 129
  • [27] Natural Products Targeting the Fungal Unfolded Protein Response as an Alternative Crop Protection Strategy
    Charpentier, Thomas
    Viault, Guillaume
    Le Ray, Anne-Marie
    Bataille-Simoneau, Nelly
    Helesbeux, Jean-Jacques
    Blon, Nadege
    Bastide, Franck
    Marchi, Muriel
    Aligon, Sophie
    Bruguiere, Antoine
    Dinh, Chau Phi
    Benbelkacem, Zahia
    Dallery, Jean-Felix
    Simoneau, Philippe
    Richomme, Pascal
    Guillemette, Thomas
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (37) : 13706 - 13716
  • [28] Natural products target pyroptosis for ameliorating neuroinflammation: A novel antidepressant strategy
    Zhang, Guangheng
    Shang, Ruirui
    Zhong, Xia
    Lv, Shimeng
    Yi, Yunhao
    Lu, Yitong
    Xu, Zhiwei
    Wang, Yilin
    Teng, Jing
    PHYTOMEDICINE, 2025, 138
  • [29] Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy
    Liu, Dan
    Chen, Lin
    Zhao, Hui
    Vaziri, Nosratola D.
    Ma, Shuang-Cheng
    Zhao, Ying-Yong
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [30] Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
    Hashem, Sheema
    Ali, Tayyiba Akbar
    Akhtar, Sabah
    Nisar, Sabah
    Sageena, Geetanjali
    Ali, Shahid
    Al-Mannai, Sharefa
    Therachiyil, Lubna
    Mir, Rashid
    Elfaki, Imadeldin
    Mir, Mohammad Muzaffar
    Jamal, Farrukh
    Masoodi, Tariq
    Uddin, Shahab
    Singh, Mayank
    Haris, Mohammad
    Macha, Muzafar
    Bhat, Ajaz A.
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150